Brian D. Dynlacht, PhD

Perlmutter Cancer Center

Professor, Department of Pathology

cancer, genome integrity, genomics, stem cell biology, systems biology

Our research program has taken advantage of multiple, complementary approaches, each aimed at understanding the mechanisms underlying progression through the mammalian cell cycle. In particular, we have chosen to focus on transcriptional mechanisms that link gene expression with cell cycle progression.

These studies have largely centered on the retinoblastoma tumor suppressor protein, pRB, and the related proteins p107 and p130. pRB is a prototypical tumor suppressor known to be mutated in many human tumors. pRB and its relatives restrain cell growth by inhibiting the activity of a cellular transcription factor, E2F, that controls the expression of key components of the cell cycle and DNA replication machinery. Using a combination of biochemistry, cell biology, and mutant cell lines, we are attempting to understand how critical gene targets are regulated by E2F and pRB. We have combined the use of a technique known as chromatin immunoprecipitation (ChIP) with a genomic approach employing DNA microarray analysis in order to begin understanding how gene regulatory networks are controlled during the cell cycle and differentiation in living mammalian cells. The pRB family controls a number of developmental decisions as well as cell cycle arrest in response to DNA damage. We hope to uncover novel targets of pRB that reveal a regulatory pathway of biologically relevant, functional interactions that drive cells toward each of these fates.

In addition to studies aimed at addressing transcriptional control of the cell cycle, we are also focusing on understanding another event linked to the cell cycle, namely duplication of centrosomes. The centrosome, involved in organizing the mitotic spindle, is poorly understood, although it was first observed 100 years ago. We have identified a novel protein, CP110, that may link the duplication of this organelle to the cell cycle. Since genomic instability ensues when CP110 is mutated, we are investigating potential links between this protein and human cancer.

Supplementary figures for Balciunaite et. al., MCB, 2005.

Lab Website
Is this your profile?
These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication

Professor, Department of Pathology

Scientific Director -Genomics Facility

PhD from University of California at Berkeley

Joachim, Justin; Razi, Minoo; Judith, Delphine; Wirth, Martina; Calamita, Emily; Encheva, Vesela; Dynlacht, Brian D; Snijders, Ambrosius P; O'Reilly, Nicola; Jefferies, Harold B J; Tooze, Sharon A

Current biology. CB. 2017 Jul 14; 27(14):2123-2136.e7

Sanchez, Irma; Dynlacht, Brian D

Developmental cell. 2017 Jul 10; 42(1):5-6

Lilja, Karin C; Zhang, Nan; Magli, Alessandro; Gunduz, Volkan; Bowman, Christopher J; Arpke, Robert W; Darabi, Radbod; Kyba, Michael; Perlingeiro, Rita; Dynlacht, Brian D

PLoS one. 2017 Apr 25; 12(4):e0176190-e0176190e0176190

Kobayashi, Tetsuo; Nakazono, Kosuke; Tokuda, Mio; Mashima, Yu; Dynlacht, Brian David; Itoh, Hiroshi

EMBO reports. 2016 Dec 27; 18(2):334-343

Fu, Wenxiang; Wang, Lei; Kim, Sehyun; Li, Ji; Dynlacht, Brian David

Cell reports. 2016 Nov 01; 17(6):1505-1517

Strikoudis, Alexandros; Lazaris, Charalampos; Trimarchi, Thomas; Galvao Neto, Antonio L; Yang, Yan; Ntziachristos, Panagiotis; Rothbart, Scott; Buckley, Shannon; Dolgalev, Igor; Stadtfeld, Matthias; Strahl, Brian D; Dynlacht, Brian D; Tsirigos, Aristotelis; Aifantis, Iannis

Nature cell biology. 2016 Nov; 18(11):1127-1138

Sanchez, Irma; Dynlacht, Brian David

Nature cell biology. 2016 Jun 28; 18(7):711-717

Wang, Lei; Lee, Kwanwoo; Malonis, Ryan; Sanchez, Irma; Dynlacht, Brian D

eLife. 2016 May 5; 5:?-?